Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Tax withholdingCommon Stock | 417 | $9.72 | $4,053.24 |
DisclosureSEC source: 0001562180-21-004274 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,595 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 21:04 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004274 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:24 UTC |
ANDO GORANDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,150 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001818 · primarydocument.xml · derivative · entry 2 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:24 UTC |
ANDO GORANDirector
|
Exercise / conversionCommon Stock | 2,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001818 · primarydocument.xml · nonDerivative · entry 1 ANDO GORAN · CIK 0001110748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:25 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001819 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,105 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F3 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:25 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,702 | $10.81 | $18,398.62 |
DisclosureSEC source: 0001562180-21-001819 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,380 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:25 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001819 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,308 shares acquired on July 31, 2020 and 970 shares acquired on January 29, 2021 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:21 UTC |
Landis John B.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001814 · primarydocument.xml · derivative · entry 2 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:21 UTC |
Landis John B.Director
|
Exercise / conversionCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001814 · primarydocument.xml · nonDerivative · entry 1 Landis John B. · CIK 0001477283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:21 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 12,467 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001813 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,466 Underlying: Common Stock · 12,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F1 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:21 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001813 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:22 UTC |
Godshall Douglas EvanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001816 · primarydocument.xml · derivative · entry 2 Godshall Douglas Evan · CIK 0001404227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:22 UTC |
Godshall Douglas EvanDirector
|
Exercise / conversionCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001816 · primarydocument.xml · nonDerivative · entry 1 Godshall Douglas Evan · CIK 0001404227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:22 UTC |
DICICCO WENDY FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001817 · primarydocument.xml · derivative · entry 2 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:22 UTC |
DICICCO WENDY FDirector
|
Exercise / conversionCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001817 · primarydocument.xml · nonDerivative · entry 1 DICICCO WENDY F · CIK 0001225165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:22 UTC |
GUYER DAVID RDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001815 · primarydocument.xml · derivative · entry 2 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Fully vested on the one-year anniversary of the grant date. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:22 UTC |
GUYER DAVID RDirector
|
Exercise / conversionCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001815 · primarydocument.xml · nonDerivative · entry 1 GUYER DAVID R · CIK 0001277476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:26 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001820 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,105 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:26 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Tax withholdingCommon Stock | 1,423 | $10.81 | $15,382.63 |
DisclosureSEC source: 0001562180-21-001820 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,592 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 00:26 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001820 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:01 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 13,717 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001521 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,718 Underlying: Common Stock · 13,717 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 21, 2020. F2 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 21, 2020. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 02:01 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001521 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 878 shares acquired on July 31, 2020 and 3,541 shares acquired on January 29, 2021 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 13:16 UTC |
Elston GeorgeChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $0.48 | $4,800.00 |
DisclosureSEC source: 0001562180-20-005930 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 13:21 UTC |
Elston GeorgeChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $0.61 | $6,112.00 |
DisclosureSEC source: 0001562180-20-005659 · primarydocument.xml · nonDerivative · entry 1 Elston George · CIK 0001429932 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:15 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 41,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004870 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,100 Underlying: Common Stock · 41,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:15 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 14,060 | $0.76 | $10,643.42 |
DisclosureSEC source: 0001562180-20-004870 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,990 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:15 UTC |
Jones David ScottSVP & Chief Commercial Officer
|
Exercise / conversionCommon Stock | 41,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004870 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:13 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 124,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004867 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,333 Underlying: Common Stock · 124,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F1 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:13 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 124,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004867 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:14 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 41,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004869 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,100 Underlying: Common Stock · 41,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:14 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Tax withholdingCommon Stock | 12,049 | $0.76 | $9,121.09 |
DisclosureSEC source: 0001562180-20-004869 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,144 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 22:14 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 41,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004869 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:40 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 40,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004716 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On June 27, 2017, the reporting person was granted 120,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F1 · derivative.expiration_date: On June 27, 2017, the reporting person was granted 120,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:40 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004716 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:52 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004723 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 27, 2017, the reporting person was granted 30,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 27, 2017, the reporting person was granted 30,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:52 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Tax withholdingCommon Stock | 2,936 | $0.79 | $2,316.50 |
DisclosureSEC source: 0001562180-20-004723 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,143 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 27, 2020 Filed Jun 30, 2020 23:52 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004723 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 27,132 | $0.00 Strike: $26.50 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 8 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 27,132 Underlying: Common Stock · 27,132 shares Expires 2029-02-21 F4 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on June 25, 2019 and was exercisable for 93,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 27,132 shares of Common Stock of the Company. F8 · derivative.exercise_date: The option vests and becomes exercisable ratably in 48 monthly installments beginning on March 21, 2019. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of May 21, 2020. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until March 21, 2023. F9 · ownership.direct: These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 27,132 | $0.00 Strike: $26.50 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 7 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,868 Underlying: Common Stock · 27,132 shares Expires 2029-02-21 F4 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on June 25, 2019 and was exercisable for 93,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 27,132 shares of Common Stock of the Company. F8 · derivative.exercise_date: The option vests and becomes exercisable ratably in 48 monthly installments beginning on March 21, 2019. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of May 21, 2020. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until March 21, 2023. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 6 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-14 F3 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on June 14, 2018 and was exercisable for 54,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 18,000 shares of Common Stock of the Company. F7 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments beginning on June 14, 2019. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of June 14, 2019. The remaining portion of the option retained by the reporting person continues to vest on an annual basis until June 14, 2021. F9 · ownership.direct: These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 5 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 18,000 shares Expires 2028-06-14 F3 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on June 14, 2018 and was exercisable for 54,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 18,000 shares of Common Stock of the Company. F7 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments beginning on June 14, 2019. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of June 14, 2019. The remaining portion of the option retained by the reporting person continues to vest on an annual basis until June 14, 2021. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $17.70 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 4 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2027-06-27 F2 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on December 15, 2017 and was exercisable for 24,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 16,000 shares of Common Stock of the Company. F6 · derivative.exercise_date: The option vested and became exercisable in three equal annual installments beginning on June 27, 2018. At the time of the transfer, the portion of the option that was transferred to the Family Trust had vested in full as of June 27, 2019. The remaining portion of the option retained by the reporting person vested in full as of June 27, 2020. F9 · ownership.direct: These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $17.70 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 3 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 16,000 shares Expires 2027-06-27 F2 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on December 15, 2017 and was exercisable for 24,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 16,000 shares of Common Stock of the Company. F6 · derivative.exercise_date: The option vested and became exercisable in three equal annual installments beginning on June 27, 2018. At the time of the transfer, the portion of the option that was transferred to the Family Trust had vested in full as of June 27, 2019. The remaining portion of the option retained by the reporting person vested in full as of June 27, 2020. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 63,750 | $0.00 Strike: $36.30 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 63,750 Underlying: Common Stock · 63,750 shares Expires 2026-09-15 F1 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share ("Common Stock"), of EyePoint Pharmaceuticals, Inc. (the "Company"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the "Family Trust"). The option was originally granted to the reporting person on December 12, 2016 and was exercisable for 85,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 63,750 shares of Common Stock of the Company. F5 · derivative.exercise_date: The option vested and became exercisable in four equal annual installments beginning on September 15, 2017. At the time of the transfer, the portion of the option that was transferred to the Family Trust had vested in full as of September 15, 2019. The remaining portion of the option retained by the reporting person vested in full as of September 15, 2020. F9 · ownership.direct: These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| June 15, 2020 Filed Feb 11, 2021 21:05 UTC |
Lurker NancyDirector · See Remarks
|
GiftStock Option (Right to Buy) · Derivative | 63,750 | $0.00 Strike: $36.30 | $0.00 |
DisclosureSEC source: 0000899243-21-005919 · doc5.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 Underlying: Common Stock · 63,750 shares Expires 2026-09-15 F1 · kind: On June 15, 2020, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share ("Common Stock"), of EyePoint Pharmaceuticals, Inc. (the "Company"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the "Family Trust"). The option was originally granted to the reporting person on December 12, 2016 and was exercisable for 85,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 63,750 shares of Common Stock of the Company. F5 · derivative.exercise_date: The option vested and became exercisable in four equal annual installments beginning on September 15, 2017. At the time of the transfer, the portion of the option that was transferred to the Family Trust had vested in full as of September 15, 2019. The remaining portion of the option retained by the reporting person vested in full as of September 15, 2020. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:03 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 45,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004517 · primarydocument.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On June 14, 2018, the reporting person was granted 135,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F1 · derivative.expiration_date: On June 14, 2018, the reporting person was granted 135,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:03 UTC |
Lurker NancyDirector · President & CEO
|
Exercise / conversionCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004517 · primarydocument.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:00 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004516 · primarydocument.xml · derivative · entry 3 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Common Stock · 14,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 14, 2018, the reporting person was granted 42,600 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 14, 2018, the reporting person was granted 42,600 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:00 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Tax withholdingCommon Stock | 4,168 | $0.83 | $3,441.10 |
DisclosureSEC source: 0001562180-20-004516 · primarydocument.xml · nonDerivative · entry 2 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,079 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:00 UTC |
Paggiarino Dario A.Chief Medical Officer
|
Exercise / conversionCommon Stock | 14,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004516 · primarydocument.xml · nonDerivative · entry 1 Paggiarino Dario A. · CIK 0001574261 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.